WHO WE ARE
How We Operate
Shire is the leading biotechnology company focused on serving people with rare diseases.
In the fight against rare disease, every day is an opportunity to win. At Shire, we'll never stop championing the fight.
Shire's National Eye C.A.R.E. Survey examines dry eye disease and the impact of today's high-tech world.
Shire continues to individualize care in rare hematology
See how much you know about VWD, the world’s most common inherited bleeding disorder.
Learn more about dry eye in this infographic.
Shire’s CEO, Flemming Ornskov, announces the close of the Shire-Baxalta combination.
View our animated infographic about the journey for patients with a rare disease.
By following this link you will be leaving a Shire controlled website for a third party website. Please note that Shire is not responsible or liable for any third party website and the website may not be appropriate for all audiences.